Cargando…

Anastasis: Return Journey from Cell Death

SIMPLE SUMMARY: Despite the development of new anticancer therapies, resistance and recurrence after treatment remain one of the greatest challenges in modern oncology. Anastasis—a recently described phenomenon—could be one explanation for why cytotoxic drugs fail to kill cancer cells. We aim to rev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaitceva, Victoria, Kopeina, Gelina S., Zhivotovsky, Boris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345212/ https://www.ncbi.nlm.nih.gov/pubmed/34359573 http://dx.doi.org/10.3390/cancers13153671

Ejemplares similares

Drug toxicity assessment: cell proliferation versus cell death
por: Sazonova, Elena V., et al.
Publicado: (2022)

The New Face of Autophagy in Chronic Lymphocytic Leukemia
por: Kopeina, Gelina S., et al.
Publicado: (2023)

A link between mitotic defects and mitotic catastrophe: detection and cell fate
por: Sazonova, Elena V., et al.
Publicado: (2021)

Anastasis: recovery from the brink of cell death
por: Tang, Ho Man, et al.
Publicado: (2018)

Platinum drugs and taxanes: can we overcome resistance?
por: Sazonova, Elena V., et al.
Publicado: (2021)

Simple and Efficient Protocol for Subcellular Fractionation of Normal and Apoptotic Cells
por: Senichkin, Viacheslav V., et al.
Publicado: (2021)

Correction to: ‘Anastasis: recovery from the brink of cell death’
por: Tang, Ho Man, et al.
Publicado: (2018)

Apoptosis regulation by subcellular relocation of caspases
por: Prokhorova, Evgeniia A., et al.
Publicado: (2018)

A molecular signature for anastasis, recovery from the brink of apoptotic cell death
por: Sun, Gongping, et al.
Publicado: (2017)

Upregulation of Mcl-1S Causes Cell-Cycle Perturbations and DNA Damage Accumulation
por: Streletskaia, Alena Y., et al.
Publicado: (2020)

Anastasis: cell recovery mechanisms and potential role in cancer
por: Mohammed, Rebar N., et al.
Publicado: (2022)

Q&A: Cellular near death experiences—what is anastasis?
por: Sun, Gongping, et al.
Publicado: (2017)

Molecular signature of anastasis for reversal of apoptosis
por: Tang, Ho Man, et al.
Publicado: (2017)

Cell death-based treatment of various diseases: a fifty-year journey
por: Kaminskyy, Vitaliy O., et al.
Publicado: (2018)

Necroptosis as a Novel Facet of Mitotic Catastrophe
por: Egorshina, Aleksandra Yu., et al.
Publicado: (2022)

Correction: Anastasis: cell recovery mechanisms and potential role in cancer
por: Mohammed, Rebar N., et al.
Publicado: (2022)

Prognostic signature based on mitochondria quality control proteins for the prediction of lung adenocarcinoma patients survival
por: Gorbunova, Anna S., et al.
Publicado: (2023)

Intratumor Heterogeneity and Therapy Resistance: Contributions of Dormancy, Apoptosis Reversal (Anastasis) and Cell Fusion to Disease Recurrence
por: Mirzayans, Razmik, et al.
Publicado: (2020)

Viral Infections: Negative Regulators of Apoptosis and Oncogenic Factors
por: Zamaraev, A. V., et al.
Publicado: (2020)

Bcl-B: an “unknown” protein of the Bcl-2 family
por: Pervushin, N. V., et al.
Publicado: (2023)

Requirement for Serine-384 in Caspase-2 processing and activity
por: Zamaraev, Alexey V., et al.
Publicado: (2020)

Transcriptomic study of anastasis for reversal of ethanol-induced apoptosis in mouse primary liver cells
por: Tang, Ho Man, et al.
Publicado: (2022)

Cell death-based treatment of neuroblastoma
por: Valter, Kadri, et al.
Publicado: (2018)

In vivo CaspaseTracker biosensor system for detecting anastasis and non-apoptotic caspase activity
por: Tang, Ho Lam, et al.
Publicado: (2015)

Return journey from Florence Congress
por: Unknown
Publicado: (1949)

Cell death-based treatment of lung adenocarcinoma
por: Denisenko, Tatiana V., et al.
Publicado: (2018)

Bak and Bcl-xL Participate in Regulating Sensitivity of Solid Tumor Derived Cell Lines to Mcl-1 Inhibitors
por: Senichkin, Viacheslav V., et al.
Publicado: (2021)

Anastasis enhances metastasis and chemoresistance of colorectal cancer cells through upregulating cIAP2/NFκB signaling
por: Wang, Ru, et al.
Publicado: (2023)

Optical Monitoring of the Biodegradation of Porous and Solid Silicon Nanoparticles
por: Gongalsky, Maxim B., et al.
Publicado: (2021)

Mitochondrial sirtuin 3 and various cell death modalities
por: Yapryntseva, Maria A., et al.
Publicado: (2022)

Step-wise formation of eukaryotic double-row polyribosomes and circular translation of polysomal mRNA
por: Kopeina, Gelina S., et al.
Publicado: (2008)

Returning to work: The cancer survivor’s transformational journey of adjustment and coping
por: Barnard, Antoni, et al.
Publicado: (2016)

Mathematical Modelling of Cell-Fate Decision in Response to Death Receptor Engagement
por: Calzone, Laurence, et al.
Publicado: (2010)

Journey to Death: Are Health Systems Failing Mothers?
por: Vora, Kranti Suresh, et al.
Publicado: (2018)

Travel burnout: Exploring the return journeys of pilgrim-tourists amidst the COVID-19 pandemic
por: Yousaf, Salman
Publicado: (2021)

Mitophagy in carcinogenesis and cancer treatment
por: Denisenko, Tatiana V., et al.
Publicado: (2021)

Autophagy and metacaspase determine the mode of cell death in plants
por: Minina, Elena A., et al.
Publicado: (2013)

The journey of resveratrol from yeast to human
por: Timmers, Silvie, et al.
Publicado: (2012)

From OPC to Oligodendrocyte: An Epigenetic Journey
por: Tiane, Assia, et al.
Publicado: (2019)

A long way to go: caspase inhibitors in clinical use
por: Dhani, Shanel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_il2c1evhprslbe0kt4shk7tneo